Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1754164
PUBLISHER: IMARC | PRODUCT CODE: 1754164
Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2025-2033
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global intravenous (IV) ibuprofen market size reached USD 7.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.45% during 2025-2033.
Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.
Intravenous (IV) Ibuprofen Market Trends:
The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.
Key Market Segmentation:
Breakup by Product Dose:
- 100 Mg Dose
- 200 Mg Dose
- 400 Mg Dose
- 800 Mg Dose
Breakup by Indication:
- Pain/Inflammatory
- Fever
Breakup by Age Group:
- Pediatrics
- Adults
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.
Key Questions Answered in This Report
- 1.What was the size of the global Intravenous (IV) ibuprofen market in 2024?
- 2.What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2025-2033?
- 3.What are the key factors driving the global Intravenous (IV) ibuprofen market?
- 4.What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
- 5.What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
- 6.What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
- 7.What are the key regions in the global Intravenous (IV) ibuprofen market?
- 8.Who are the key players/companies in the global Intravenous (IV) ibuprofen market?
Product Code: SR112025A6440
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Intravenous (IV) Ibuprofen Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Dose
- 6.1 100 Mg Dose
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 200 Mg Dose
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 400 Mg Dose
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 800 Mg Dose
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Pain/Inflammatory
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Fever
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Age Group
- 8.1 Pediatrics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Adults
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Cumberland Pharmaceuticals Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Hyloris Pharmaceuticals SA
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Recordati Rare Diseases Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 VALMOR Laboratories CA
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Xgen Pharmaceuticals Djb Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.1 Cumberland Pharmaceuticals Inc.
Product Code: SR112025A6440
List of Figures
- Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
- Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2024
- Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2024
- Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2024
- Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2024
- Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2024
- Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
- Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
- Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million USD), 2025-2033
- Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million USD), 2025-2033
- Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
- Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
- Table 7: Global: Intravenous Ibuprofen Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.